TRADING UPDATES: Aptamer gets more Unilever work; Creo "confident"
21st Jul 2025 19:59
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Price | 13.125p on 11-08-2025 | at 14:54:56
---|---|
Change | 0.00p 0% |
Buy | 13.50p |
Sell | 12.75p |
Last Trade: | Sell 8,155.00 at 12.75p |
Day's Volume: | 283,054 |
Last Close: | 13.125p |
Open: | 13.125p |
ISIN: | GB00BZ1BLL44 |
Day's Range | 13.125p - 13.125p |
52wk Range: | 9.30p - 32.50p |
Market Capitalisation: | £54.14m |
VWAP: | 12.84286p |
Shares in Issue: | 412.47m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Creo Medical (CREO) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 8,155 | 12.75p | Ordinary |
15:54:55 - 11-Aug-25 |
Sell* | 7 | 12.75p | SI Trade |
15:28:21 - 11-Aug-25 |
Buy* | 19 | 13.50p | SI Trade |
15:28:21 - 11-Aug-25 |
Sell* | 12 | 12.75p | SI Trade |
15:28:21 - 11-Aug-25 |
Buy* | 82 | 13.50p | SI Trade |
15:28:21 - 11-Aug-25 |
Sell* | 8 | 12.75p | SI Trade |
15:28:21 - 11-Aug-25 |
Sell* | 943 | 12.75p | SI Trade |
15:28:21 - 11-Aug-25 |
Sell* | 40 | 12.75p | SI Trade |
15:28:21 - 11-Aug-25 |
Buy* | 143 | 13.50p | SI Trade |
15:28:21 - 11-Aug-25 |
Sell* | 44 | 12.75p | SI Trade |
15:28:21 - 11-Aug-25 |
Creo Medical (CREO) Regulatory News |
||
Date | Source | Headline |
---|---|---|
4th Aug 2025 7:00 am | RNS-R | Speedboat® patient testimonial |
24th Jul 2025 7:00 am | RNS | Award of Shares under SIP and Director Dealings |
21st Jul 2025 7:00 am | RNS | H1’25 Trading Update |
10th Jul 2025 7:00 am | RNS-R | MicroBlate™ Flex begins lung tumour clinical study |
9th Jul 2025 9:41 am | RNS | PDMR Options Revision |
30th Jun 2025 7:00 am | RNS | Change of Nominated Adviser |
26th Jun 2025 11:08 am | RNS | Result of AGM |
26th Jun 2025 7:00 am | RNS | AGM Statement and Directorate Changes |
11th Jun 2025 7:00 am | RNS-R | U.S. FDA clearance for SpydrBlade™ Flex |
2nd Jun 2025 7:00 am | RNS | Director/PDMR Shareholding |